Role of vesicle-associated syntaxin 5 in the assembly of pre-Golgi intermediates

Science

Volumn 279, Issue 5351, 1998, Pages 696-700

  Rowe, Tony ^a   Dascher, Christiane ^a   Bannykh, Sergei ^a   Plutner, Helen ^a   Balch, William E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTAXIN;

ANIMAL CELL; ARTICLE; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; KIDNEY CELL; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBODIES; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; MANNOSE-BINDING LECTINS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; N-ETHYLMALEIMIDE-SENSITIVE PROTEINS; ORGANELLES; QA-SNARE PROTEINS; QB-SNARE PROTEINS; QC-SNARE PROTEINS; R-SNARE PROTEINS; RATS; SNARE PROTEINS; VESICULAR STOMATITIS-INDIANA VIRUS; VESICULAR TRANSPORT PROTEINS; VIRAL ENVELOPE PROTEINS;

ANIMALIA;

EID: 0032579295     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.279.5351.696     Document Type: Article

References (48)

1. C. Dascher, J. Matteson, W. E. Balch, J. Biol. Chem. 269, 29363 (1994).
2. K. G. Hardwick and H. R. B. Pelham, J. Cell Biol. 119, 513 (1993).
3. T. Söllner, M. K. Bennett, S. W. Whiteheart, R. H. Scheller, J. E. Rothman, Cell 75, 409 (1993).
4. M. K. Bennett and R. H. Scheller, Proc. Natl. Acad. Sci. U.S.A. 90, 2559 (1993).
5. M. K. Bennett et al., Cell 74, 863 (1993).
6. D. K. Banfield, M. J. Lewis, C. Rabouille, G. Warren, H. R. B. Pelham, J. Cell Biol. 127, 357 (1994).
7. J. Saraste and K. Svensson, J. Cell Sci. 100, 415 (1991).
8. J. Saraste and E. Kuismanen, Cell 38, 535 (1984).
9. S. I. Bannykh, T. Rowe, W. E. Balch, J. Cell Biol. 135, 19 (1996).
10. M. Aridor, S. I. Bannykh, T. Rowe, W. E. Balch, ibid. 131, 875 (1995).
11. B. L. Tang, S. H. Low, H.-P. Hauri, W. Hong, Eur. J. Cell Biol. 68, 397 (1995).
12. R. Schekman and L. Orci, Science 271, 1526 (1996).
13. J. E. Rothman and F. Wieland, ibid. 272, 227 (1996).
14. T. Rowe, M. Aridor, J. M. McCaffery, H. Plutner, W. E. Balch, J. Cell Biol. 135, 895 (1996).
15. T. Rowe and W. E. Balch, unpublished results.
16. C. Walch-Solimena et al., J. Cell Biol. 128, 637 (1995).
17. C. Dascher and W. E. Balch, J. Biol. Chem. 271, 15866 (1996).
18. C. J. M. Beckers, D. S. Keller, W. E. Balch, Cell 50, 523 (1987).
19. H. W. Davidson and W. E. Balch, J. Biol. Chem. 268, 4216 (1993).
20. J. C. Hay, D. S. Chao, C. S. Kuo, R. H. Scheller, Cell 89, 149 (1997).
21. N. Hui et al., Mol. Biol. Cell 8, 1777 (1997).
22. T. Söllner et al., Nature 362, 318 (1993).
23. A. Mayer, W. Wickner, A. Haas, Cell 85, 83 (1996).
24. H. Otto, P. I. Hanson, R. Jahn, Proc. Natl Acad. Sci. U.S.A. 94, 6197 (1997).
25. G. J. Steel, M. Tagaya, P. G. Woodman, EMBO J. 15, 745 (1996).
26. M. Sacher, S. Stone, S. Ferro-Novick, J. Biol. Chem. 272, 17134 (1997).
27. J. P. Lian, S. Stone, Y. Jiang, P. Lyons, S. Ferro-Novick, Nature 372, 698 (1994).
28. M. Sögaard et al., Cell 78, 937 (1994).
29. W. E. Balch, J. M. McCaffery, H. Plutner, M. G. Farquhar, ibid. 76, 841 (1994).
30. H. Plutner, H. W. Davidson, J. Saraste, W. E. Balch, J. Cell Biol. 119, 1097 (1992).
31. B. J. Nichols, C. Ungermann, H. R. B. Pelham, T. Wickner, A. Haas, Nature 387, 199 (1997).
32. L. H. Chamberlain, D. Roth, A. Morgan, R. D. Burgoyne, J. Cell Biol. 130, 1063 (1995).
33. A. Banerjee, V. A. Barry, B. R. DasGupta, T. F. J. Martin, J. Biol. Chem. 271, 20223 (1996).
34. P. I. Hanson, R. Roth, H. Morisaki, R. Jahn, J. E. Heuser, Cell 90, 523 (1997).
35. C. Barlowe et al., ibid. 77, 895 (1994).
36. J. F. Presley et al., Nature 389, 81 (1997).
37. S. Bannykh and W. E. Balch, J. Cell Biol. 138, 1 (1997).
38. T. E. Kreis, EMBO J. 5, 931 (1986).
39. A. Velasco et al., J. Cell Biol. 122, 39 (1993).
40. D. W. Wilson, S. W. Whiteheart, M. Wiedmann, M. Brunner, J. E. Rothman, ibid. 117, 531 (1992).
41. S. Fleischer and M. Kervina, Methods Enzymol. 31, 6 (1974).
42. V. Malhotra, T. Serafini, L Orci, J. C. Shepherd, J. E. Rothman, Cell 58, 329 (1989).
43. NRK cells on cover slips were infected at the restrictive temperature (39.5°C) with the tsO45 strain of VSV (30). The cells were subsequently shifted to either 15° or 32°C, then permeabilized with digitonin and probed with the appropriate primary antibodies followed by fluorescently labeled secondary antibodies (30). The primary antibodies used were directed against Syn5 (17), VSV-G (p5D4) (38), and α-1,2-mannosidase II (39).
44. NRK cells were infected with tsO45 VSV for 4 hours at 39.5°C, then transferred to ice and permeabilized (18). Transport reactions containing semi-intact cells, gel-filtered cytosol, ATP mix, and uridine 5′-triphosphate-N-acetylglucosamine were performed for 60 min at 32°C and the membranes subsequently digested with endo D and β-N-acetylglucosaminidase (19). Syntaxin 5-specific reagents were preincubated in complete reaction cocktails on ice for 20 min before transfer to 32°C. Processing of VSV-G to the endo D-sensitive form was followed by quantitative immune blotting (14).
45. Vesicle formation and two-stage assays were done as described (14) with the following modifications: (i) The membranes were resuspended in 0.25 M sucrose, 10 mM Hepes (pH 7.4) before the addition of salts and differential centrifugation; (ii) the medium speed spin was increased to 5 min in the two-stage assay; and (iii) stage 2 incubations contained gel-filtered cytosol (19). Endo D digestion was performed as described above.
46. Immunoisolated ER-derived vesicles (14) were solubilized in 0.5% Triton X-100 buffers containing either ATP and EDTA (assembly) or MgATP (disassembly) (22). For immunoprecipitation experiments, the vesicle extracts (0.4 ml) were incubated with 0.5 mg of α-SNAP and Myc-NSF immobilized on anti-Myc-coupled magnetic beads. The immunoprecipitates were washed extensively before SDS-polyacrylamide gel electrophoresis (PAGE) and immune blotting. Analysis on 10 to 40% (w/v) glycerol density gradients was done as described (40). Fractions were collected and precipitated with 10% trichloroacetic acid before SDS-PAGE and immune blotting with enhanced chemiluminescence detection.
47. 2, 20 mM Hepes (pH 7.4)], then resuspended in 4 ml of transport buffer plus PIC. The Golgi membranes were divided into 0.1-ml samples, frozen in liquid nitrogen, and stored at -80°C.
48. We thank R. Scheller and J. Hay (Stanford University) for antibodies to mSec22b, rBet1, and membrin; J. Saraste (University of Bergen, Bergen, Norway) for anti-p58; and S. Whiteheart (University of Kentucky Medical Center) for recombinant α-SNAP, Myc-tagged NSF, and anti-NSF (6E6). Supported by NIH grant GM 42336 (to W.E.B.) and the National Cancer Institute (CA58689). Electron microscopy made extensive use of Core B in CA58689. T.R. is a recipient of a fellowship from the Muscular Dystrophy Association, C.D. is a recipient of a fellowship grant from the Deutsche Forschungsgemeinschaft, and S.B. is a recipient of a Cystic Fibrosis Foundation Fellowship.